Announcements Trials
Browse Landscape

Status

Completed 45Recruiting 25Terminated 9Withdrawn 5Unknown 5Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 119Neoplasms 100Lung Neoplasms 66Colorectal Neoplasms 62Carcinoma, Hepatocellular 56Carcinoma, Non-Small-Cell Lung 53Prostatic Neoplasms 48Uterine Cervical Neoplasms 36Pancreatic Neoplasms 36Stomach Neoplasms 29Ovarian Neoplasms 28Disease 28Rectal Neoplasms 27Multiple Myeloma 25Leukemia, Myeloid, Acute 21Head and Neck Neoplasms 21Esophageal Neoplasms 21Endometrial Neoplasms 21Recurrence 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Colonic Neoplasms 18Neoplasm Metastasis 17Glioma 17Glioblastoma 17Melanoma 15Lymphoma 15Cholangiocarcinoma 14Urinary Bladder Neoplasms 13Neoplasm, Residual 13Liver Neoplasms 12

Interventions

Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × Central Nervous System Neoplasms × Clear all
NCT05850377 2023-05-09

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Sociedad de Lucha Contra el Cáncer del Ecuador

Not yet recruiting
90 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡